Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Other OTC  >  CytoDyn Inc.    CYDY

CYTODYN INC.

(CYDY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about CYTODYN INC.
03/05CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and..
GL
03/05CytoDyn's Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and..
GL
03/03CytoDyn Files Form S-3 to Replace Expiring Shelf Registration Statement
GL
02/22CytoDyn in Discussions with U.S. FDA, MHRA and Health Canada After Unblinding..
GL
02/05INSIDER TRENDS : Insider at CytoDyn Converts Options in Mist of 90-Day Buying Tr..
MT
02/01CYTODYN  : Chiral Pharma Corp. to Assist Philippine Physicians Apply for Compass..
AQ
01/29Chiral Pharma Corp. to Assist Philippine Physicians Apply for Compassionate S..
GL
01/05CYTODYN  : to Hold Webcast on January 6 to Provide Timelines for Clinical and Re..
AQ
01/04REMINDER : CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinica..
GL
2020CytoDyn Announces Research on Critically Ill COVID-19 Patients Published in J..
GL
2020FDA Accepts Protocol for Adding an Open-Label Extension to CytoDyn's Phase 3 ..
GL
2020CYTODYN  : to Hold Webcast on January 6 to Provide Timelines for Clinical and Re..
AQ
2020CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Re..
GL
2020FDA Provides Guidance for Adding an Open-Label Extension to CytoDyn's Phase 3..
GL
2020FDA Resumes eIND Approval for Severe-to-Critical COVID-19 Patients Use of Vyr..
GL
More most relevant news
All news about CYTODYN INC.
03/05CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and..
GL
03/05CytoDyn's Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and..
GL
03/03CytoDyn Files Form S-3 to Replace Expiring Shelf Registration Statement
GL
03/02CYTODYN INC.  : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/22CytoDyn in Discussions with U.S. FDA, MHRA and Health Canada After Unblinding..
GL
02/05INSIDER TRENDS : Insider at CytoDyn Converts Options in Mist of 90-Day Buying Tr..
MT
02/01CYTODYN  : Chiral Pharma Corp. to Assist Philippine Physicians Apply for Compass..
AQ
01/29Chiral Pharma Corp. to Assist Philippine Physicians Apply for Compassionate S..
GL
01/29CYTODYN INC.  : Entry into a Material Definitive Agreement, Unregistered Sale of..
AQ
01/08CYTODYN  : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
More news
News in other languages on CYTODYN INC.
2020CYTODYN INC.  : protocole d'accord pour mener un essai clinique COVID-19
More news
Press releases
03/05CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and..
GL
03/05CytoDyn's Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and..
GL
03/03CytoDyn Files Form S-3 to Replace Expiring Shelf Registration Statement
GL
03/02CYTODYN INC.  : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/22CytoDyn in Discussions with U.S. FDA, MHRA and Health Canada After Unblinding..
GL
More press releases
Upcoming sector events